DEF: PEDEVCO Corp. Details 2025 Annual Meeting, Board Elections, and Auditor Change Following Financial Restatement
Definitive Proxy Statement
PEDEVCO Corp. has released its definitive proxy statement outlining proposals for its 2025 virtual annual meeting, including the election of five directors and the ratification of a new independent auditor, following a financial restatement that increased prior period net income.
Summary
- The 2025 annual meeting of stockholders will be held virtually on Thursday, August 28, 2025, at 10:00 a.m. Central Standard Time.
- Stockholders will vote on the election of five directors and the ratification of Weaver and Tidwell, L.L.P. as the independent auditors for the fiscal year ending December 31, 2025.
- The board of directors unanimously recommends voting 'FOR' all director nominees and 'FOR' the ratification of the auditor.
- As of the record date, June 30, 2025, there were 91,829,352 shares of common stock outstanding and entitled to vote.
- The company recently restated its consolidated financial statements for the years ended December 31, 2023, and 2022, due to an overstatement of depletion expense related to oil and gas properties, which resulted in an overall increase in net income for the affected periods.
- Dr. Simon G. Kukes transitioned from Chief Executive Officer to Executive Chairman effective January 1, 2025, and J. Douglas Schick was promoted to President and Chief Executive Officer and joined the board on the same date.
- Jody D. Crook was appointed Chief Commercial Officer effective January 1, 2025, and John K. Howie was appointed to the Board of Directors effective July 7, 2025.
- Marcum LLP was dismissed as the independent registered public accounting firm on July 1, 2025, and Weaver and Tidwell, L.L.P. was engaged on July 7, 2025.
Sentiment
Score: 7
Explanation: The document is primarily a procedural proxy statement. While it discloses a financial restatement, the outcome of that restatement was an increase in net income, which is a positive adjustment. The company also highlights its adherence to strong corporate governance practices, including meeting independence requirements despite its controlled status, and planned executive transitions appear orderly. No new negative operational or financial news is presented beyond what was previously disclosed.
Positives
- The financial restatement for 2022 and 2023 resulted in an overall increase in net income for the affected periods, indicating a positive correction to prior financial reporting.
- The company maintains a robust corporate governance structure, opting to meet NYSE American listing rules for smaller reporting companies, including having a board comprised of at least 50% independent directors and independent compensation, nominating, and governance committees, despite its 'controlled company' status.
- All Section 16(a) reports for executive officers and directors are believed to have been timely filed during 2024.
- The company has a Clawback Policy in place, effective October 2, 2023, to recover erroneously awarded incentive-based compensation, aligning with SEC rules.
Negatives
- The company identified and corrected material errors in its prior financial statements (2022 and 2023) related to depletion expense, necessitating a restatement.
- The company does not have a formal policy on equity ownership for executives and directors, though all Named Executive Officers and directors are beneficial owners of company stock.
- The company has not historically looked to net income (loss) as a specific performance measure for its executive compensation program, which may not directly align with shareholder value creation based on profitability.
Risks
- Forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including those described in the Annual Report on Form 10-K for the year ended December 31, 2024.
- The company operates in a very competitive and rapidly changing environment, with new risks emerging over time.
- Management cannot predict all risks or assess the impact of all factors on the business, which may cause actual results to differ materially and adversely from anticipated or implied forward-looking statements.
Future Outlook
The company's forward-looking statements are based on current expectations and projections about future events and trends, acknowledging that actual results could differ materially due to various risks and uncertainties in a competitive and rapidly changing environment. The company does not assume any obligation to update this information, except as required by federal securities laws.
Management Comments
- Dr. Simon G. Kukes, Executive Chairman, stated: 'The board of directors and officers of PEDEVCO Corp., a Texas corporation, join me in extending to you a cordial invitation to attend the 2025 annual meeting of our stockholders.'
- Dr. Simon G. Kukes, Executive Chairman, also noted: 'Your vote and participation in our governance is very important to us.'
- The Board, including the independent directors, unanimously recommends voting 'FOR' each of the director nominees and 'FOR' Proposal Two (auditor ratification).
Industry Context
The company operates within the oil and gas industry, which is characterized by a very competitive and rapidly changing environment. The expertise of the board members and executive officers, particularly in oil and gas management, finance, engineering, and business development, is highlighted as crucial for navigating this dynamic sector.
Comparison to Industry Standards
- N/A
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Chairman of the Board of Directors | John J. Scelfo (Chairman of the Board) | Dr. Simon G. Kukes | 2025-01-01 | Dr. Kukes stepped down from Chief Executive Officer and assumed the Executive Chairman position as part of a leadership structure change. |
| Chief Executive Officer, President, and Director | Dr. Simon G. Kukes (Chief Executive Officer) | J. Douglas Schick | 2025-01-01 | Promotion from President as part of a leadership structure change, and joined the board of directors. |
| Chief Commercial Officer | N/A | Jody D. Crook | 2025-01-01 | Appointment to a new executive officer position, previously served as Senior Advisor for Land and Business Development. |
| Director | N/A | John K. Howie | 2025-07-07 | Appointment to the Board of Directors. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Leadership Structure | Transitioned from a combined CEO/Chairman role to separate Executive Chairman (Dr. Simon G. Kukes) and CEO (J. Douglas Schick) positions, effective January 1, 2025. This structure aims to allocate authority and oversight between management and the board. | 2025-01-01 | Expected to enhance oversight and strategic direction by clearly delineating responsibilities between operational leadership and board oversight. |
| Director Independence | The board has determined that Mr. Scelfo, Mr. Evans, and Mr. Howie are independent directors, ensuring over 50% of the board members are independent, aligning with NYSE American rules for smaller reporting companies despite the company's 'controlled company' status. | N/A | Strengthens corporate governance and aligns with best practices for public companies, enhancing investor confidence. |
| Clawback Policy Adoption | Adopted a Policy for the Recovery of Erroneously Awarded Incentive-Based Compensation to comply with SEC and NYSE rules, allowing for mandatory recovery of incentive compensation from current and former officers in the event of an accounting restatement. | 2023-10-02 | Enhances accountability for executive compensation and financial reporting accuracy, aligning executive incentives with long-term company performance and compliance. |
| Auditor Change | Dismissed Marcum LLP and engaged Weaver and Tidwell, L.L.P. as the independent registered public accounting firm for the fiscal year ending December 31, 2025. | 2025-07-01 (dismissal), 2025-07-07 (engagement) | A routine change in auditors, with no reported disagreements or reportable events with the previous firm, suggesting a smooth transition without adverse implications for financial reporting integrity. |
Related Party Transactions
- Equity issuances to executive officers and directors as part of compensation for services rendered, including restricted common stock grants in January 2023, August 2023, January 2024, August 2024, and July 2025.
- Employment agreements with current Named Executive Officers (J. Douglas Schick, Clark R. Moore, Paul A. Pinkston, Jody D. Crook) detailing salaries, bonuses, and other compensation terms, including severance provisions for Mr. Moore.
Stakeholder Impact
- Shareholders: Will participate in corporate governance through voting on director elections and auditor ratification; impacted by the financial restatement (which increased net income) and executive compensation practices.
- Employees: Affected by executive compensation policies, including equity awards and bonus structures; new executive appointments may influence company direction.
- Customers and Suppliers: No direct impact mentioned, but stable corporate governance and financial health indirectly support business relationships.
- Creditors: Financial restatement and ongoing financial reporting practices provide transparency regarding the company's financial condition.
Next Steps
- Hold the 2025 virtual annual meeting of stockholders on August 28, 2025.
- File a Current Report on Form 8-K within four business days following the annual meeting to publish the final voting results.
- The next stockholder advisory vote on executive compensation ('say-on-pay') is expected at the 2026 annual meeting.
- The next stockholder advisory vote on the frequency of 'say-on-pay' votes is also expected at the 2026 annual meeting.
Key Dates
| Date | Description |
|---|---|
| 2022-12-31 | Fiscal year end for which financial statements were restated. |
| 2023-01-23 | Company issued restricted common stock and options in connection with 2022 annual compensation review. |
| 2023-08-31 | Company granted restricted common stock to Mr. John Scelfo and Mr. H. Douglas Evans. |
| 2023-11-08 | Board of directors adopted the Policy for the Recovery of Erroneously Awarded Incentive-Based Compensation (Clawback Policy). |
| 2023-12-31 | Fiscal year end for which financial statements were restated. |
| 2024-01-26 | Company issued restricted common stock and options in connection with 2023 annual compensation review. |
| 2024-02-01 | Effective date for salary increases for Mr. J. Douglas Schick and Mr. Paul A. Pinkston. |
| 2024-05-24 | 70,000 shares of restricted common stock forfeited due to employee termination. |
| 2024-06-27 | Board of directors adopted an amended and restated 2021 Equity Incentive Plan to increase available shares. |
| 2024-08-29 | Stockholders approved the amended and restated 2021 Equity Incentive Plan; Company granted restricted common stock to Mr. John Scelfo and Mr. H. Douglas Evans. |
| 2024-12-07 | Jody Crook appointed Chief Commercial Officer. |
| 2024-12-08 | Offer Letter with Jody Crook dated. |
| 2024-12-31 | Fiscal year end for the 2024 Annual Report on Form 10-K. |
| 2025-01-01 | Effective date for Dr. Simon G. Kukes' transition to Executive Chairman, J. Douglas Schick's promotion to CEO and board membership, and Jody D. Crook's appointment as Chief Commercial Officer; Mr. Schick's salary increased. |
| 2025-01-23 | Board approved calendar year 2024 cash bonuses for executive officers. |
| 2025-03-25 | Current Report on Form 8-K filed regarding depletion expense errors. |
| 2025-03-28 | Audit Committee concluded depletion expense errors were material to 2023 and 2022 financial statements. |
| 2025-03-31 | Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC. |
| 2025-06-30 | Record date for determining stockholders entitled to vote at the 2025 annual meeting. |
| 2025-07-01 | Marcum LLP dismissed as the company's independent registered public accounting firm. |
| 2025-07-07 | John K. Howie appointed to the Board of Directors; Weaver and Tidwell, L.L.P. engaged as the new independent registered public accounting firm; Company granted 150,000 shares of restricted common stock to Mr. Howie. |
| 2025-07-08 | Current Report on Form 8-K filed to report the dismissal of Marcum. |
| 2025-07-11 | Date of the Dear Stockholder letter and Notice of Annual Meeting and Proxy Statement; E-proxy notice sent on or about this date. |
| 2025-07-12 | Vesting date for Mr. John Scelfo's restricted stock award. |
| 2025-08-28 | Date of the 2025 Annual Meeting of Stockholders. |
| 2025-09-27 | Vesting date for Mr. H. Douglas Evans' restricted stock award. |
| 2025-11-23 | Vesting date for certain unvested shares of common stock for Dr. Kukes, Mr. Schick, Mr. Moore, Mr. Pinkston, and Mr. Crook. |
| 2026-01-19 | Expiration date for options under the 2012 Plan. |
| 2026-01-23 | Vesting date for certain unvested shares of common stock for Dr. Kukes, Mr. Schick, Mr. Moore, and Mr. Pinkston. |
| 2026-01-26 | Vesting date for certain unvested shares of common stock for Dr. Kukes, Mr. Schick, Mr. Moore, Mr. Pinkston, and Mr. Crook. |
| 2026-03-17 | Deadline for stockholder proposals for inclusion in 2026 proxy materials under Rule 14a-8. |
| 2026-05-30 | Earliest date for stockholder proposals and director nominations for the 2026 annual meeting under company bylaws. |
| 2026-06-29 | Deadline for Rule 14a-19 notification for 2026 annual meeting. |
| 2026-07-07 | Vesting date for Mr. John K. Howie's restricted stock award. |
| 2026-07-09 | Latest date for stockholder proposals and director nominations for the 2026 annual meeting under company bylaws. |
| 2026-11-23 | Vesting date for certain unvested shares of common stock for Dr. Kukes, Mr. Schick, Mr. Moore, Mr. Pinkston, and Mr. Crook. |
| 2027-01-26 | Vesting date for certain unvested shares of common stock for Dr. Kukes, Mr. Schick, Mr. Moore, Mr. Pinkston, and Mr. Crook. |
| 2027-11-23 | Vesting date for certain unvested shares of common stock for Dr. Kukes, Mr. Schick, Mr. Moore, Mr. Pinkston, and Mr. Crook. |
| 2031-07-01 | Termination date of the 2021 Equity Incentive Plan. |
Keywords
PEDEVCO Corp., Proxy Statement, Annual Meeting, Corporate Governance, Executive Compensation, Financial Restatement, Auditor Change, Board of Directors, SEC Filing, Oil and Gas, Shareholder Vote, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.